Matches in Wikidata for { <http://www.wikidata.org/entity/Q64625352> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q64625352 description "clinical trial" @default.
- Q64625352 description "ensayu clínicu" @default.
- Q64625352 description "klinisch onderzoek" @default.
- Q64625352 description "клінічне випробування" @default.
- Q64625352 description "կլինիկական փորձարկում" @default.
- Q64625352 name "A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects" @default.
- Q64625352 type Item @default.
- Q64625352 label "A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects" @default.
- Q64625352 prefLabel "A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects" @default.
- Q64625352 P1132 Q64625352-D3876D64-D37A-4026-B939-62644B9D24E5 @default.
- Q64625352 P1476 Q64625352-CA57E9C8-E735-4460-B03D-073F2D7A786D @default.
- Q64625352 P17 Q64625352-D73A9E1F-EE74-47FE-BAAF-8676BB6D9479 @default.
- Q64625352 P2899 Q64625352-91A14D47-64F4-4376-97AF-299DBDC528C0 @default.
- Q64625352 P3098 Q64625352-85BCAFCD-EB2E-4D2C-9836-135BD9334651 @default.
- Q64625352 P31 Q64625352-F127B65C-A753-40C9-A47E-A9884E4B0545 @default.
- Q64625352 P4135 Q64625352-1981969B-EA92-42E6-95A5-B3B3D059E869 @default.
- Q64625352 P580 Q64625352-0DD197EA-D81A-4CD3-8004-3C1C122AB02C @default.
- Q64625352 P582 Q64625352-314E7A69-33FA-4883-A664-AB7DAE660F44 @default.
- Q64625352 P6099 Q64625352-71B7B677-51C4-4BF0-8FB2-6DF267414AED @default.
- Q64625352 P6153 Q64625352-0397A125-1A48-4850-A191-174D58749519 @default.
- Q64625352 P8363 Q64625352-F14084E2-F6A7-4095-A3F4-31114FB68BCD @default.
- Q64625352 P859 Q64625352-90AF8578-6442-40D6-AB4B-BBCB55AF3F50 @default.
- Q64625352 P1132 "+12" @default.
- Q64625352 P1476 "A Three-Part Phase I, Open-Label, Single Ascending Dose, and A Single-Blind, Placebo-Controlled, Repeat Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Relative Bioavailability of Intravenous and Oral GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects" @default.
- Q64625352 P17 Q30 @default.
- Q64625352 P2899 "+18" @default.
- Q64625352 P3098 "NCT01818011" @default.
- Q64625352 P31 Q30612 @default.
- Q64625352 P4135 "+65" @default.
- Q64625352 P580 "2013-08-07T00:00:00Z" @default.
- Q64625352 P582 "2013-10-18T00:00:00Z" @default.
- Q64625352 P6099 Q5452194 @default.
- Q64625352 P6153 Q212322 @default.
- Q64625352 P8363 Q78089383 @default.
- Q64625352 P859 Q212322 @default.